SCHEDULE 13G/A: Armistice Capital and Steven Boyd Disclose 9.99% Stake in Rockwell Medical

Armistice Capital, LLC and Steven Boyd have disclosed a beneficial ownership of 9.99% of Rockwell Medical, Inc.'s common stock as of December 31, 2024.

Summary

• Armistice Capital, LLC and Steven Boyd (collectively, the "Reporting Persons") have filed an Amendment No. 3 to Schedule 13G regarding their beneficial ownership in Rockwell Medical, Inc.
• As of December 31, 2024, the Reporting Persons collectively beneficially own 3,249,178 shares of Rockwell Medical, Inc. Common Stock.
• This ownership represents 9.99% of the total outstanding shares of Rockwell Medical, Inc.
• Armistice Capital, LLC, a Delaware entity, serves as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.
• Steven Boyd, a U.S. citizen, is the managing member of Armistice Capital, LLC and is deemed to beneficially own the securities held by the Master Fund.
• The filing indicates that the Reporting Persons hold shared voting power and shared dispositive power over all 3,249,178 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer, nor in connection with any transaction having such purpose or effect, other than activities solely in connection with a nomination under SEC rules.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain explicit positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Armistice Capital Master Fund Ltd., a Cayman Islands exempted company, is an investment advisory client of Armistice Capital, LLC and has the right to receive dividends from, or the proceeds from the sale of, the reported securities.

Stakeholder Impact

• Shareholders: The disclosure of a significant 9.99% stake by an investment firm like Armistice Capital could be viewed by other shareholders as a vote of confidence or could signal potential future engagement, though the filing explicitly states it is not for control purposes.

Key Dates

Keywords

Rockwell Medical, Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, Shareholding, SEC Filing